Molecule
Apixaban; LC-ESI-QFT; MS2; CE: 120%; R=15000; [M+H]+
Apixaban; LC-ESI-QFT; MS2; CE: 15%; R=15000; [M+H]+
Apixaban; LC-ESI-QFT; MS2; CE: 30%; R=15000; [M+H]+
Apixaban; LC-ESI-QFT; MS2; CE: 45%; R=15000; [M+H]+
Apixaban; LC-ESI-QFT; MS2; CE: 60%; R=15000; [M+H]+
Apixaban; LC-ESI-QFT; MS2; CE: 75%; R=15000; [M+H]+
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
Chemical Information
6 Related Dataset(s)
⌄
Metadata Information
| Field | Value |
|---|---|
| NFDI4Chem Molecule ID | nfdi4chem-mol60458 |
| Source | |
| Alternate Name |
| Field | Value |
|---|---|
| No additional information available for this Dataset. | |
| Data-Source Molecule ID | Data-Source |
|---|---|
| CHEMBL231779 | ChEMBL |
| 56310620 | PubChem: Drugs of the Future |
| GG2 | PDBe |
| APIXABAN | DailyMed |
| 19023 | BindingDB |
| APIXABAN | rxnorm |
| BMS-562247 | clinicaltrials |
| APIXABAN | clinicaltrials |
| ELIQUIS | clinicaltrials |
| HY-50667 | MedChemExpress |
| BMS-562247-01 | clinicaltrials |
| DTXSID80436500 | EPA CompTox Dashboard |
| 4298 | DrugCentral |
| 6390 | Guide to Pharmacology |
| J2.566.952E | Nikkaji |
| HMDB0248515 | Human Metabolome Database |
| NUPQEW | CCDC |
| ELIQUIS | rxnorm |
| 10182969 | PubChem |
| PD009294 | ProbesDrugs |
| 3Z9Y7UWC1J | FDA SRS |
| 503612-47-3 | ACToR |
| DB06605 | DrugBank |
| Apixaban(BMS-562247-01) | Selleck |
| 72296 | ChEBI |
| 15178464 | PubChem: Thomson Pharma |
| SCHEMBL118023 | SureChEMBL |
| 32278100 | eMolecules |
| LSM-45660 | LINCS |
| CB51508586 | ChemicalBook |
| 3564 | Brenda |
| ZINC000011677837 | ZINC |
| PA166163740 | PharmGKB |
| apixaban | DailyMed |
| 85842 | Brenda |
| The data in this table is sourced from UniChem at EBI. | |